Evaluation of MELD score and maddrey discriminant function for mortality prediction in patients with alcoholic hepatitis

Hepato-Gastroenterology

Volumn 60, Issue 125, 2013, Pages 1089-1094

  Monsanto, Pedro ^a   Almeida, Nuno ^a   Leŕias, Clotilde ^a   Cabral, José Eduardo Pina ^a   Sofia, Carlos ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Alcoholic hepatitis; Alcoholic liver disease; Maddrey discriminant function score; Model for end stage liver disease score

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CORTICOSTEROID; CREATININE; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; PENTOXIFYLLINE; SODIUM;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER DISEASE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DEMOGRAPHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; MADDREY DISCRIMINANT FUNCTION MODEL; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL;

ADULT; AGED; DISCRIMINANT ANALYSIS; END STAGE LIVER DISEASE; FEMALE; HEPATITIS, ALCOHOLIC; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84885830099     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11969     Document Type: Article

References (27)

1. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr.: Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75:193-199. (Pubitemid 8372264)
2. Carithers RL Jr, Herlong HF, Diehl AM, et al.: Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989; 110:685-690. (Pubitemid 19121221)
3. Srikureja W, Kyulo NL, Runyon BA, Hu KQ: MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol 2005; 42:700-706.
4. Sheth M, Riggs M, Patel T: Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002; 2:2.
5. Soultati AS, Dourakis SP, Alexopoulou A, Deutsch M, Vasilieva L, Archimandritis AJ: Predicting utility of a model for end stage liver disease in alcoholic liver disease. World J Gastroenterol 2006; 12:4020-4025. (Pubitemid 44097111)
6. Dunn W, Jamil LH, Brown LS, et al.: MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005; 41:353-358. (Pubitemid 40165379)
7. Forrest EH, Evans CD, Stewart S, et al.: Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005; 54:1174-1179. (Pubitemid 41025916)
8. Louvet A, Naveau S, Abdelnour M, et al.: The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007; 45:1348-1354. (Pubitemid 46918318)
9. Wiesner RH, McDiarmid SV, Kamath PS, et al.: MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7:567-580. (Pubitemid 32677880)
10. Kamath PS, Wiesner RH, Malinchoc M, et al.: A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470. (Pubitemid 32119037)
11. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871. (Pubitemid 30169932)
12. Mathurin P, Duchatelie V, Ramond MJ, et al.: Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996; 110:1847-1853. (Pubitemid 26169222)
13. Kulkarni K, Tran T, Medrano M, Yoffe B, Goodgame R: The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. J Clin Gastroenterol 2004; 38:453-459.
14. Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C: Systematic review: glucocorticosteroids for alcoholic hepatitis - a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther 2008; 27:1167-1178. (Pubitemid 351697274)
15. Mathurin P, Abdelnour M, Ramond MJ, et al.: Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 2003; 38:1363-1369. (Pubitemid 37466961)
16. Mendenhall C, Anderson S, Garcia-Pont P, et al.: Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984; 311:1464-1470. (Pubitemid 15211021)
17. Mathurin P, Mendenhall C, Carithers Jr R, et al.: Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002; 36:547-548.
18. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L: Prognostic factors in alcoholic liver disease. Am J Gastroenterol 1991; 86:210-216.
19. Kumashiro R, Sata M, Ishii K, et al.: Prognostic factors for short-term survival in alcoholic hepatitis in Japan: analysis by logistic regression. Alcohol Clin Exp Res 1996; 20:383A-338A.
20. Borzio M, Salerno F, Piantoni L, et al.: Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33:41-48. (Pubitemid 32186174)
21. Louvet A, Wartel F, Castel H, et al.: Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology 2009; 137:541-548.
22. Whitfield K, Rambaldi A, Wetterslev J, Gluud C: Pentoxifylline for alcoholic hepatitis. Cochrane Database Syst Rev 2009; 4:CD007339.
23. Lebrec D, Thabut D, Oberti F, et al.: Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology 2010; 138:1755-1762.
24. O'Shea RS, Dasarathy S, McCullough AJ: Practice guideline committee of the american association for the study of liver diseases; practice parameters committee of the american college of gastroenterology. Alcoholic liver disease. Hepatology 2010; 51:307-328.
25. Maher JJ: Alcoholic steatohepatitis: management and prognosis. Curr Gastroenterol Rep 2007; 9:39-46.
26. Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C: Systematic review: glucocorticosteroids for alcoholic hepatitis - a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther 2008; 27:1167-1178. (Pubitemid 351697274)
27. Mathurin P, O'Grady J, Carithers RL, et al.: Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 2011; 60:255-260.